EZR and endometrioid adenocarcinoma: A high expression of ezrin was related to poor outcome, which supported findings in HNSCC [23], ESCC [28], NSCLC [31], salivary gland adenoid cystic carcinoma [49], nasopharyngeal cancer [50], and endometrioid carcinoma [52].